Jan Stahlberg

CIK: 0001983161

Transaction Breakdown

Open Market Buys (P)17 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

DMAC

DiaMedica Therapeutics Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (17 total)

DMAC
DiaMedica Therapeutics Inc.
Nov 25, 2025
Purchase(P)
Indirect
73.1K shares at avg. $8.57$627K
DMAC
DiaMedica Therapeutics Inc.
Nov 24, 2025
Purchase(P)
Indirect
40.3K shares at avg. $7.89$318K
DMAC
DiaMedica Therapeutics Inc.
Nov 21, 2025
Purchase(P)
Indirect
208.9K shares at avg. $7.41$1.5M
DMAC
DiaMedica Therapeutics Inc.
Nov 20, 2025
Purchase(P)
Indirect
128.4K shares at avg. $7.41$951K
DMAC
DiaMedica Therapeutics Inc.
Nov 19, 2025
Purchase(P)
Indirect
240.4K shares at avg. $7.21$1.7M
DMAC
DiaMedica Therapeutics Inc.
Nov 18, 2025
Purchase(P)
Indirect
182.9K shares at avg. $6.75$1.2M
DMAC
DiaMedica Therapeutics Inc.
Nov 17, 2025
Purchase(P)
Indirect
187.4K shares at avg. $6.52$1.2M
DMAC
DiaMedica Therapeutics Inc.
Aug 27, 2025
Purchase(P)
Indirect
50.8K shares at avg. $6.00$305K
DMAC
DiaMedica Therapeutics Inc.
Aug 26, 2025
Purchase(P)
Indirect
59.6K shares at avg. $6.00$358K
DMAC
DiaMedica Therapeutics Inc.
Aug 25, 2025
Purchase(P)
Indirect
338.3K shares at avg. $6.00$2.0M
DMAC
DiaMedica Therapeutics Inc.
Aug 22, 2025
Purchase(P)
Indirect
59.8K shares at avg. $5.96$357K
DMAC
DiaMedica Therapeutics Inc.
Aug 21, 2025
Purchase(P)
Indirect
48.2K shares at avg. $5.96$287K
DMAC
DiaMedica Therapeutics Inc.
Aug 20, 2025
Purchase(P)
Indirect
71.1K shares at avg. $5.86$416K
DMAC
DiaMedica Therapeutics Inc.
Aug 15, 2025
Purchase(P)
Indirect
8.2K shares at avg. $6.00$49K
DMAC
DiaMedica Therapeutics Inc.
Aug 14, 2025
Purchase(P)
Indirect
70.4K shares at avg. $5.99$422K
DMAC
DiaMedica Therapeutics Inc.
Aug 13, 2025
Purchase(P)
Indirect
293.6K shares at avg. $5.91$1.7M
DMAC
DiaMedica Therapeutics Inc.
Jul 23, 2025
Purchase(P)
Indirect
1.5M shares at avg. $3.50$5.4M

		Type	Shares	Price		Ownership
Nov 25, 2025	DMAC DiaMedica Therapeutics Inc.	Purchase(P)	73,099	$8.57	$626,817	Indirect
Nov 24, 2025	DMAC DiaMedica Therapeutics Inc.	Purchase(P)	40,253	$7.89	$317,721	Indirect
Nov 21, 2025	DMAC DiaMedica Therapeutics Inc.	Purchase(P)	208,872	$7.41	$1,547,574	Indirect
Nov 20, 2025	DMAC DiaMedica Therapeutics Inc.	Purchase(P)	128,426	$7.41	$951,213	Indirect
Nov 19, 2025	DMAC DiaMedica Therapeutics Inc.	Purchase(P)	240,352	$7.21	$1,732,361	Indirect
Nov 18, 2025	DMAC DiaMedica Therapeutics Inc.	Purchase(P)	182,882	$6.75	$1,234,618	Indirect
Nov 17, 2025	DMAC DiaMedica Therapeutics Inc.	Purchase(P)	187,393	$6.52	$1,221,165	Indirect
Aug 27, 2025	DMAC DiaMedica Therapeutics Inc.	Purchase(P)	50,772	$6.00	$304,632	Indirect
Aug 26, 2025	DMAC DiaMedica Therapeutics Inc.	Purchase(P)	59,648	$6.00	$357,888	Indirect
Aug 25, 2025	DMAC DiaMedica Therapeutics Inc.	Purchase(P)	338,265	$6.00	$2,029,252	Indirect
Aug 22, 2025	DMAC DiaMedica Therapeutics Inc.	Purchase(P)	59,788	$5.96	$356,576	Indirect
Aug 21, 2025	DMAC DiaMedica Therapeutics Inc.	Purchase(P)	48,172	$5.96	$287,028	Indirect
Aug 20, 2025	DMAC DiaMedica Therapeutics Inc.	Purchase(P)	71,107	$5.86	$416,495	Indirect
Aug 15, 2025	DMAC DiaMedica Therapeutics Inc.	Purchase(P)	8,233	$6.00	$49,398	Indirect
Aug 14, 2025	DMAC DiaMedica Therapeutics Inc.	Purchase(P)	70,414	$5.99	$421,921	Indirect
Aug 13, 2025	DMAC DiaMedica Therapeutics Inc.	Purchase(P)	293,601	$5.91	$1,734,918	Indirect
Jul 23, 2025	DMAC DiaMedica Therapeutics Inc.	Purchase(P)	1,542,857	$3.50	$5,400,000	Indirect

1-17 of 17 transactions

About STAHLBERG JAN

STAHLBERG JAN (SEC CIK 0001983161) files insider reports with the SEC as 10% Owner of DiaMedica Therapeutics Inc. (DMAC).

Signal8 holds 3 ownership filings by STAHLBERG JAN, all Form 4s, filed between Jul 25, 2025 and Dec 8, 2025. Those filings report 17 transactions, from Jul 23, 2025 to Nov 25, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on STAHLBERG JAN's filings is in STOCKHOLM, V7.

Recent filings by STAHLBERG JAN

Nov 25, 2025: Open-market purchase of DMAC shares (Form 4, code P).
Nov 24, 2025: Open-market purchase of DMAC shares (Form 4, code P).
Nov 21, 2025: Open-market purchase of DMAC shares (Form 4, code P).
Nov 20, 2025: Open-market purchase of DMAC shares (Form 4, code P).
Nov 19, 2025: Open-market purchase of DMAC shares (Form 4, code P).

Other insiders filing for DiaMedica Therapeutics Inc. (DMAC)

Pauls Dietrich John, President & CEO
Giuffre Randall Michael, Director
Kuntz Richard, Director
O'Connor Daniel J., Director
Lewis Tanya, Director
Semba Charles Pauling, Director

How to read Form 4 transaction codes